Ask HN: How to be my own genetic disease researcher for my partner?
I feel like it would be impossible for a doctor to stay abreast of all of the possible links/data unless they focused very narrowly on a patient.
I'd like to try and fill that gap - look at the data and relay any potential links/causes to the providers.
We have the full genome in CRAM, CRAI, FASTQ, VCF, and TBI data - is there a way that me, a medical layman but well informed person could leverage this data to mine for possible matching genetic variants?
e.g. I have started finding genes associated with my partner's condition in the NCBI website and the ClinVar Miner (https://clinvarminer.genetics.utah.edu/variants-by-condition)
Is it sufficient to identify variants by searching for the SNP string (e.g. "rsXXXXXX") in the VCF file?
Are there "hacker's guide to genomic analysis" resources out there?
84 comments
[ 3.4 ms ] story [ 190 ms ] thread[1] https://www.promethease.com/
As far as discovering new associations or causal relationships from a single WGS, you are probably not going to have any luck there.
1. Search for variants in that genome where the allele frequency is close to 0 in a very large population e.g. https://gnomad.broadinstitute.org/
2. Look into variant effects for those you prioritized in step 1 using https://www.ensembl.org/info/docs/tools/vep/index.html
Rare diseases are typically due to a coding mutation that alters the protein coding sequence in some significant way.
If you need help contact details are on my profile. I do this for a living at a university.
rsIDs are a minefield as they change often, there are synonyms and probably you won't have all loci properly annotated. Don't rely on that too much unless you really know what you are doing.
If it's not a rare disease, this gets quite more difficult. Also, depending on the whole genome sequencing platform you have used, many structural variants (e.g. deletions or insertions of large chunks of DNA) won't be easy to measure.
Other comments have suggested Promethease, which will give you a bit of help if it's not a rare disease (e.g. if it's an autoimmune one, it's good at imputing HLA and finding risk haplotypes).
My whole comment is a bit of an oversimplification, but I think these suggestions are a good starting point.
Love your offer to help.
My son was born 3 months ago with Poland syndrome. This came as a shock but it has also drawn me to look into the scientific literature.
While the common belief was that PS has no underlying genetic cause, there are papers suggesting that the may be.
Studying - I ran across many anomalies on my own body (his father), so minor that there were never considered relevant until now (I'm 40 and lead a normal life).
It would seem that on the right side of my body I have at least:
If the above is correct, this may be an opportunity (by studying my genome and my son's genome) to establish a link or a common cause for Becker Nevus Syndrome and Poland Syndrome - both fairly rare anomalies.Can you suggest who may be interested in studying this?
This has no value for me or my son, however the scientific endeavour may be of value for the future.
https://www.matchmakerexchange.org/
It's incredibly inspiring to have an example like yours. Thank you so much for trying to connect with researchers to help them understand the disease, even though it "has no value for you or your son." Your attempt has a lot of value as a model to follow. I'll try to do the same thing if we end up in a similar position. Good luck!
I've never heard of this correlation and have friends that became parents at 50 so I am curious.
I know that the older you get, the riskier it is to have children, but had no idea it was a linear correlation.
From https://news.ycombinator.com/item?id=28650922:
> A woman’s peak reproductive years are between the late teens and late 20s. By age 30, fertility (the ability to get pregnant) starts to decline. This decline becomes more rapid once you reach your mid-30s. By 45, fertility has declined so much that getting pregnant naturally is unlikely for most women.
> Down syndrome (trisomy 21) is the most common chromosome problem that occurs with later childbearing. The risk of having a pregnancy affected by Down syndrome is
> 1 in 1,480 at age 20
> 1 in 940 at age 30
> 1 in 353 at age 35
> 1 in 85 at age 40
> 1 in 35 at age 45 [2]
My jaw dropped.
I probably shouldn't claim "birth defects" in the general sense, just Down syndrome specifically. But the wording of "most common chromosome problem" seems to imply that this is a pretty reasonable inference.
Had no idea I was risking my kiddo's health so much by waiting.
1 in 35 is a lot.
Thanks for that!
There is a lot of studies on Google Scholar and it goes back to the 1800's. Some studies in livestock or vegetation (crops mainly) can also illicit clues because despite being different some chemical reactions or some end results will be the same in humans and animals and plants. You just cant change some of the chemical reactions, melatonin be one that is seen in humans, animals and plants, it increases in darkness.
I'd also love to help OP :)
I haven't worked on this problem, but others in my graduate lab did. If you're interested in a tool that automates some of this process (takes VCF as input; filters variants based on frequency; you'll need to map disease symptoms/phenotypes to Human Phenotype Ontology [1] identifiers), some of my former lab mates developed a web tool [2]: https://amelie.stanford.edu/submit
[1] https://hpo.jax.org/app/
[2] https://www.medrxiv.org/content/10.1101/2020.12.29.20248974v...
(I do not want to demotivate but please be cautious. Even the best analysts have 'only' around 50% case-solve rate. If it is an adult-onset-disease, chances can be lower as the disease mechanism in that case may not be 'consequential' enough to be naturally selected against)
OP, how did you even get the sequence to begin with? I have a friend who has an immunodeficiency which is almost certainly due to a rare genetic disorder and want to do a very similar thing. Despite contacting his physician, fellow researchers, and even my institution's president -- with friend's full cooperation -- no one is willing to pay for it.
I'm at my wit's end to the point that I'm starting to think the only viable option is paying for it out of pocket, but it's not cheap.
A question you might want to ponder is: suppose you isolate the problem to a single missense/nonsense/truncation mutation in a protein that seems likely to cause the phenotype. How do you plan to use that information? In theory, there is gene therapy, but in reality, given how much effort I have had to go through just to get this fellow sequenced -- and I'm a PhD working in genomics with a lot of contacts -- creating a custom one-off gene therapy solution seems like it would be a very tremendous undertaking.
There is a very difficult problem here in that rare or "personalized" disease treatments are: A) not profitable, so drug companies have no interest, B) there are mountains of paperwork, IRBs, consent waivers, etc, involved in developing an experimental therapeutic, C) by definition you cannot do a proper clinical trial on a one-off, and D) it requires several different types of expertise to pull such a thing off. Sadly this means that it almost never happens, even though I suspect there are a lot of severe and lifelong genetic disorders which could be diagnosed and treated with technology available today.
Based on my experience so far, I suspect that even if you were to hand his physician very strong evidence that "the problem is caused by this specific single mutation", the response will be "OK, thanks". You should not make strong assumptions about them being able to take it from there. All this is based on the best-case scenario of it being a single variant in a coding region; if the disorder is caused by multiple variants at different loci, anything you find will probably not be actionable.
My neurologist ordered sequencing for me from Invitae, to determine the subtype of Ehlers-Danlos I have and rule out neuromuscular diseases. She said insurance usually covers it, and it's only a few hundred bucks if they don't. Invitae appears to do WGS for such panels. I've also heard of Nebula genomics offering affordable WGS and exome sequencing.
She said she'd take a look at the results, and if anything popped out as unusual, I'd see a geneticist.
> A question you might want to ponder is: suppose you isolate the problem to a single missense/nonsense/truncation mutation in a protein that seems likely to cause the phenotype. How do you plan to use that information?
Identify the molecular pathway involved and see if there's any drugs available that might modulate it in a therapeutic way. You might also identify similar diseases that might share similar treatments, once you know the etiology.
Once a mutation or gene responsible is identified, other patients can be as well, which can slowly lead to mouse models and clinical trials etc.
You get to keep all the raw data from the sequencing and you will get some reports included. I did it in order to do a genetic disease screening as I was very sick with strange symptoms for a long time.
I'll be looking into it further to figure out whether there is some tradeoff here, or if it is just typical cost bloat for medicine/academia.
Another avenue might be a crowdsourced rare disease research organization like [2]
I have no relation to any of the above but read a book about the UDN that may be of interest to you: [3]
[1] https://undiagnosed.hms.harvard.edu/apply/
[2] https://www.researchtothepeople.org/
[3] https://www.goodreads.com/en/book/show/53317420-the-genome-o...
Hunting down my son's killer: https://matt.might.net/articles/my-sons-killer/
You may also want to email him. Anecdotally, I believe the rare disease research community is small and willing to listen to outliers.
University department page: https://www.uab.edu/medicine/pmi/matt-might
(Edit: fixed urls, typos, grouping.)
This was it and seems relevant: http://www.cureffi.org/2019/04/29/financial-modeling-in-rare...
For more just start learning the tools... I have not checked in on them for years now but "BioStars Handbook" was up & coming
[] https://github.com/webyrd/mediKanren [] https://biostar.myshopify.com/
would recommend trying to find supervision from an expert rather than just diving in alone. every field has its nuance.
https://www.reddit.com/r/Nebulagenomics/comments/nhjfpa/how_...
You use the VCF and a java project called the Exomiser, and it will give you output files with all the pathogenic variants marked
In my case and is the case with a lot of rare diseases you could have unique pathology and mutations in a certain gene but that don't show up as pathogenic in clin var. For example my family has a lot of autoimmune diseases and as expected my HLA genes are totally trashed. However none of these mutations have ever been seen and flagged before especially was WGS is so new.
If you only have a list of genes and the genomizer will give you a list of the genes that are the most heaviy affected, you can put them into this app to get some further data and idea about what kind of tissue expression or rare disease spectrums you may be dealing with: https://maayanlab.cloud/Enrichr/
you can make informed decisions on it like for example I have a defect in my thiamine transport gene, so now I follow a b1 megadose protocol. A lot of people do that with the basic 23and me methylation reports but this is more in depth. So in my family maybe this looks like parkinsonanism, autism, diabetes, muscle disease, metaboloic syndrome, but we're understanding these diseases to be more like mitochondrial diseases that are more systemic. The answers you get are often really just too cutting edge for GPs or even specialists to deal with and you have better luck just researching, biohacking or talking to a natropath. Genetics doesn't really have that place in general practice yet unless it's something like a very very clear pathogenic marker which honestly isn't the case in a lot of cases, or alternatively you end up having a "pathogenic" marker that we had no idea even exists in people who aren't gravely disabled. For example I don't have lissencephaly regardless of what my pathogeniticty says. instead in that case you look at the gene, and see the big picture which that it's linked to neurodevelopmental disorders, and I have autism so that could be a factor there. But autism != lissencephaly. WGS is so new
sadly the reality is though you can have all that and it almost puts you at a disadvatnage with doctors because you look crazy and sus claiming you have some HLA mutation or whatever. Who told you that? Oh well I data mined it...uh huh sure....honestly to get it back into the medical system and to be taken seriously you'd probably have to get a doctor to retest it, for example I can can spin this up to get my HLA alleles from my fastq https://github.com/nf-core/hlatyping
But no doctor is going to put that in my medical record until I convince them to run a blood test for the same damn thing.
if anyone wants to help me with my own genetic search woes and help me out or know solutions please let me know. if you want to help me publish or add to that guide somewhere let me know - i asked nebula if they wanted to print it on the blog and they said the'd be interested but I just never cleaned it up
The thing is, if you sequence your genome, you might have used a protocol that has a label on it: “Not for diagnostic purposes, research only“. A doctor shouldn’t take anything that’s not IVD-certified seriously(and for good reasons).
https://www.cureffi.org/about/
Sonia: https://www.broadinstitute.org/bios/sonia-vallabh
Eric: https://www.broadinstitute.org/bios/eric-minikel
They are also hiring: https://broadinstitute.wd1.myworkdayjobs.com/broad_institute...
Genetics is very hard, and in very good case you may get 10% correlation. Then you will have to convince specialists to chase this weak possibility...
Working on this will consume your time, and put you under stress. This energy could be spend on your partner instead. You will need a lot of energy it it progresses.
Also there is always a big chance of misdiagnosis. Simple stuff like food alergy can be mistaken for many illnesses. Perhaps best first action is to verify this diagnosis. Get second opinion. Or change environment to rule out common triggers.
Nothing wrong with research...if there are existing tools within reach (and it seems like there are) then it seems like it'd be interesting and possibly helpful to dive in. But I'd strongly encourage you to timebox it as a project so it doesn't grow into something unhealthy.
I strongly recommend that you start by consulting with multiple doctors until you find one or more who shows interest in your partner's case, understands probable causes, and demonstrates useful expertise in treatment. You may need to visit a larger hospital that is involved in research. Work the system. You are a recruiter.
Pick the primary doctor who will coordinate your partner's treatment. This doctor will be your partner's primary line of defense, and they will mentor you in any investigations you do. They will guide you through the maze of therapies, palliative care, research, social workers, and other forms of support. They will connect you to other specialists who can help.
Good luck!
You may find something, you may not, a lot is unknown and regions outside of the genes may be affected and even the cause of the phenotype, but we still understand very little of this.
Depending on where you live, genomic counseling is free and trio sequencing is usually part of it.
This is not really my expertise (more in oncology) but feel free to ask more questions.
If you have BAM (or CRAM + reference genome) files for parents and your partner, you could download a trial of VarSeq [0] to do a more GUI based analysis of the results.
"Is it sufficient to identify variants by searching for the SNP string (e.g. "rsXXXXXX") in the VCF file?" If the variants have been associated with the same phenotype as your partner's, then yes, it is interesting. If there is no phenotype, perhaps you can track down the source publication and try to talk to the authors.
There are probably groups online with people in the same situation, try to find them, they can probably help you a lot more.
[0]: https://www.goldenhelix.com/products/VarSeq/index.html
Admittedly, your situation is different. Still, your partner may need you more as a supporting, fun, optimistic person rather than the miserable piece of human you can become from a bottomless rabbit hole like genomics, where the answer to your partner's problem may forever seem like "almost within your grasp".
As for the data, I assume you've done Illumina sequencing. Your files are as follows:
FASTQ: short reads of the genome. CRAM: the reads aligned against a reference genome. VCF: small (probably <50bp, mostly SNPs) variants between your partner's genome and the reference, including your partner's genotypes (We are diploid, so there are two homologous copies of almost all loci in the genome, so you can have a variant that's in homozygosis---same alleles-- or heterozygosis--- different alleles.) The other files are index files that trivially describe the layout of these.
A substantial fraction of rare genetic disease (maybe 20%) relates to alleles found in the exome (the portion of the genome that directly codes for proteins in a 1:1 manner). You can look for rare variants that have significant effect on proteins. In most Illumina data sets, the significant majority of these will be genotyping or variant detection errors. Even ones that seem to lie in genes that are important for the etiology of your partner's phenotype are likely to be errors.
Other posters have linked to tools that might you predict the effect of given variants. You might also look at the variant effect predictor (VEP): https://grch37.ensembl.org/info/docs/tools/vep/index.html. This will classify the predicted effects of variants based on extremely detailed annotations of the genome. You can then find variants with high effect that are rare or nonexistent in the observed human population (using gnomad). Rare variants of highly deleterious functional effect with allele frequency >0% that your partner has in homozygosis may be candidates to follow up on. You will also want to look for variants that have AF=0% in the larger population and high effect size and your partner has in heterozygosis (they could be "dominant").
My impression is that most rare genetic disease is related to structural variation. This lies outside the scope of the short read resequencing which you've done. We don't even yet know the magnitude of this, because there are so few truly de novo assemblies of rare disease patients. The required technology has only come online in the past two years.
Between problems of observation of the genome and interpretation of the significance of variants, your job is not going to be easy. You will be confused by the signals you get, and probably follow many incorrect leads. Good luck.
Maybe you could find researchers working on his topic (your disease or the generic problem of identifying causal mutations for a disease) and pay them to work on your case?
You might fight your own parking ticket but you'd get a lawyer for your murder defence...
Computer people get paid a hella lot more than university medical research people, especially those outside big cities or in Europe or Asia. It's more efficient to work hard at making money and hire a few experts.
An important first step is to consider the probability that this is a condition with a genetic basis, based on what is already known about it.
Her story might give you some pointers. All the best to you and your partner.
I'll second the suggestion to use Exomiser, or its more expansive version called Genomiser.
No, it is not sufficient to look up the RS numbers in the VCF file. There are two reasons for this:
1. The RS number just refers to the location. Different variants can exist at one location, so you aren't necessarily finding the same variant. Variants need to be matched by location and by the change that they cause.
2. RS numbers are typically given to locations that have common variants, although there are numerous exceptions. It is a universal rule of genetics that a rare monogenic disease cannot be caused by a common variant. This fact was so obvious, but it needed to be published [0] before people started taking it seriously. So mostly likely the variant that is causing the disease does not have an RS number.
The main problem you will face is the sheer quantity of data that you have been given. The average person has something like 3 million variants, so you need a way to whittle these down to a short list. The first thing you need to do is get rid of all the common variants, for the reason stated above. The easiest way to do this is to annotate the variants using software like VEP, Annovar, or alamut-batch. I'd recommend VEP because it is good, popular, and free. That will include in its output whether the variant has been found in the GnomAD project [1], which is a conglomeration of thousands of genome sequences, and can therefore say whether the variant is common or rare. For the variant to be considered rare, it shouldn't be present in GnomAD more than a couple of times.
Once you have the variants annotated, you should know for each variant whether it is inside a gene, which gene that is, and whether the variant has an effect on coding. If a variant is intronic, it is unlikely to be pathogenic (although it is never that simple). Common mechanisms of pathogenicity are:
1. If the variant changes the protein code (a missense variant). These are hard to interpret - they may be pathogenic but most are not.
2. If the variant changes the length of the coding DNA by a factor of three (an in-frame indel), which inserts/deletes amino acids from the protein. These are slightly more likely to be pathogenic than missense variants, but most are still not.
3. If the variant changes the length of the coding DNA by something other than a factor of three (a frameshift indel). This messes up the frame of the three-base code of the gene, making the rest of the gene gibberish. These are much more likely to be pathogenic, but only if the gene itself is actually important.
4. If the variant changes a protein codon into a "stop" codon (a "stop gain" or "nonsense" variant). These are as likely to be pathogenic as a frameshift.
5. If the variant interferes with splicing (a splicing variant). These variants are on the borders of the exons of genes and may change the way that the introns are cut out of the gene before translation into protein. These are fairly likely to be pathogenic.
The annotations should tell you which of these things a variant might be. A synonymous or intronic variant that doesn't affect splicing is very unlikely to be relevant.
You need to determine whether the disease is likely to be recessive or dominant. Recessive means that you need to have both copies of the gene broken in order to get the disease, whereas dominant means that you need just one copy broken in order to get the disease. If you look the disease or gene in ClinVar or OMIM [2] you can often find whether the gene is recessive or dominant. If it is recessive, you either need to find two pathogenic variants that are heterozygous, or you need to find a single pathogenic variant that is homozygous. In the VCF file, a variant is heterozygous if it says "0/1" and homo...
Link?